戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 cific CD4(+) T cells robustly expressing the integrin alpha4beta1.
2 EGF-A, induce lymphatic vessel expression of integrin alpha4beta1.
3 lation of the T-cell antigen receptor or the integrin alpha4beta1.
4 in that serves as a ligand for the leukocyte integrin, alpha4beta1.
5 amily, as validated with a distantly related integrin, alpha4beta1.
6 macological inhibition of MLCK210 suppresses integrin alpha4beta1 activation, as well as tumor inflam
7 yosin-dependent Rap1 GTP loading, leading to integrin alpha4beta1 activation.
8 ese hamster ovary cells that express defined integrins (alpha4beta1, alpha5beta1, or both), and cell
9                                              Integrins alpha4beta1, alpha5beta1, alpha6Abeta1, alphav
10                                              Integrins alpha4beta1, alpha5beta1, and alphavbeta3 and
11 t soluble uPAR (suPAR) specifically binds to integrins alpha4beta1, alpha6beta1, alpha9beta1, and alp
12 st small molecule agonist identified for the integrin alpha4beta1 (also known as very late antigen-4
13    We show here that the fibronectin-binding integrin alpha4beta1 and its ligand fibronectin are nove
14                           Here, we show that integrin alpha4beta1 and RGD-binding integrins (alphaVbe
15                        Our studies show that integrin alpha4beta1 and the signals it transduces regul
16           Intercellular adhesion mediated by integrin alpha4beta1 and vascular cell adhesion molecule
17                  These studies indicate that integrin alpha4beta1 and VCAM-1 facilitate a critical ce
18 adhesion mediated by the interaction between integrin alpha4beta1 and VCAM-1 is important in normal p
19 an endothelial cell ligand for two leukocyte integrins (alpha4beta1 and alpha4beta7).
20                 The fibronectin (FN)-binding integrins alpha4beta1 and alpha5beta1 confer different c
21  CC chemokine receptor 9, and binding of the integrins alpha4beta1 and alphaLbeta2 to their respectiv
22       This result suggests that at least two integrins, alpha4beta1 and an RGD-directed, non-alpha5be
23 t VEGFR1+ cells express VLA-4 (also known as integrin alpha4beta1), and that tumour-specific growth f
24 ed T cell activation, enhanced expression of integrin alpha4beta1, and infiltration of activated T ce
25 al conformational equilibrium set points for integrin alpha4beta1 are cell type specific and differ f
26                The IDAPS motif implicated in integrin alpha4beta1 binding is at the FN13-14 junction,
27 igand for very late Ag-4 (VLA-4; also called integrin alpha4beta1) binding cells in granulomas, and c
28                               Antagonists of integrin alpha4beta1, but not of other integrins, blocke
29                               Antagonists of integrin alpha4beta1, but not other integrins, blocked t
30                     Chemokine stimulation of integrin alpha4beta1-dependent T lymphocyte adhesion is
31                 Stimulation by chemokines of integrin alpha4beta1-dependent T-lymphocyte adhesion is
32 mature naive T cells was sufficient to drive integrin alpha4beta1 expression and CNS migration, where
33 nduced lymphangiogenesis, as genetic loss of integrin alpha4beta1 expression in Tie2Cre+ alpha4(loxp/
34              Progenitor cells, which express integrin alpha4beta1, homed to sites of active tumor neo
35    We demonstrate that ectopic expression of integrin alpha4beta1 in animal cap cells results in atta
36 es indicate the usefulness of antagonists of integrin alpha4beta1 in suppressing macrophage colonizat
37 e sequence recognized by the closely related integrin alpha4beta1, in the inducible endothelial ligan
38                  Furthermore, antagonists of integrin-alpha4beta1 inhibited chemotherapy-induced tumo
39 accurately predict poor disease outcome, and integrin alpha4beta1 is a biomarker of lymphatic endothe
40                                              Integrin alpha4beta1 is a receptor for vascular cell adh
41                                              Integrin alpha4beta1 is expressed by proliferating but n
42                         We conclude that the integrin alpha4beta1 is important for survival of develo
43                             We conclude that integrin alpha4beta1 is necessary for CD4(+) T cell-medi
44 e encoding the alpha4 subunit of alpha4beta1 integrin (alpha4beta1) is essential for this migratory p
45      Very late antigen-4 (VLA-4; also called integrin alpha4beta1) is a transmembrane noncovalent het
46  metastatic disease, these results show that integrin alpha4beta1-mediated tumor lymphangiogenesis pr
47                                              Integrin alpha4beta1 mediates leukocyte recruitment, act
48   alpha9beta1, like the structurally related integrin alpha4beta1, mediates accelerated cell migratio
49 odes promotes tumor metastasis by activating integrin alpha4beta1 on lymph node lymphatic endothelium
50 ecific peptidomimetic ligand (LLP2A) against integrin alpha4beta1 on the MSC surface to a bisphosphon
51 ients, these results indicate that targeting integrin alpha4beta1 or VCAM to inhibit the interactions
52 ereas genetic or pharmacological blockade of integrin alpha4beta1 or VCAM-1 inhibits it.
53  interactions in shear flow of cells bearing integrins alpha4beta1 or alpha4beta7 with VCAM-1 and MAd
54               Antibodies blocking FN binding integrins alpha4beta1 or alphaVbeta1, but not alpha5beta
55              The most prominent cell-surface integrin alpha4beta1 partner, a 70-kDa protein, was isol
56 l phenotype and exhibited elevated levels of integrin alpha4beta1, potentially making these cells les
57                                    Activated integrin alpha4beta1 promotes expansion of the lymphatic
58                                          The integrin alpha4beta1 recognizes an LDVP sequence in the
59                               A non-I-domain integrin, alpha4beta1, recognizes vascular cell adhesion
60 gration, whereas pharmacologic inhibition of integrin alpha4beta1 reduced the abnormal T cell presenc
61                                Inhibition of integrin-alpha4beta1, SDF-1alpha, or IL-1beta was suffic
62                  In addition, antagonists of integrin alpha4beta1 suppress lymphangiogenesis and tumo
63 mical cross-linking to identify sequences in integrin alpha4beta1 that are involved in its interactio
64 vation, leading to conformational changes in integrin alpha4beta1 that promote myeloid cell extravasa
65                                              Integrin alpha4beta1 then promotes growth factor and tum
66 n and paxillin with the cytoplasmic tails of integrin-alpha4beta1, thereby stimulating myeloid cell a
67             Erythroid cells express only one integrin, alpha4beta1, throughout differentiation, and i
68 eta (IL-1beta) collaborate with myeloid cell integrin-alpha4beta1 to promote tumor inflammation and g
69 o cell types and was partly dependent on the integrin alpha4beta1 (very late activation 4[VLA-4]) and
70  with monoclonal antibodies (MoAbs) enhanced integrin alpha4beta1 (very late antigen [VLA]-4) and alp
71 m and precursor cells (NPCs) expresses VLA4 (integrin alpha4beta1, very late antigen-4) that facilita
72                            Here we show that integrin alpha4beta1 (VLA-4) and VCAM-1 promote close in
73                            Here we show that integrin alpha4beta1 (VLA-4) promotes the homing of circ
74                           Here, we show that integrin alpha4beta1 (VLA4) promotes the invasion of tum
75 ously shown the constitutive activity of the integrin, alpha4beta1 (VLA4), on a unique subpopulation
76  addition of 12G10 mAb to cells adhering via integrin alpha4beta1 was found to trigger disruption of